{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:50:43Z","timestamp":1788439843258,"version":"build-2803163510"},"reference-count":42,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rabies is a highly fatal disease, and it is vital to find effective ways to manage and control infection. There is a need for new effective antiviral drugs that are particularly effective treatments for rabies. Deoxynivalenol (DON) is known mainly for its toxicity, but at the molecular level, it can inhibit RNA and DNA replication, and there is increasing evidence that different doses of DON have a positive effect on inhibiting virus replication. Based on this, we evaluated the effect of DON on inhibiting the rabies virus in vitro. The inhibitory effect of DON on rabies virus activity was dose- and time-dependent, and 0.25 \u03bcg\/mL of DON could inhibit 99% of rabies virus activity within 24 h. Furthermore, DON could inhibit the adsorption, entry, replication, and release of rabies virus but could not inactivate the virus. The inhibitory effect of DON on rabies virus may be achieved by promoting apoptosis. Our study provides a new perspective for the study of anti-rabies virus and expands the direction of action of mycotoxins.<\/jats:p>","DOI":"10.3390\/ijms24097793","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T02:06:35Z","timestamp":1682388395000},"page":"7793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Deoxynivalenol Mycotoxin Inhibits Rabies Virus Replication In Vitro"],"prefix":"10.3390","volume":"24","author":[{"given":"Qian","family":"Liu","sequence":"first","affiliation":[{"name":"NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyang","family":"Zhu","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1099\/jgv.0.001269","article-title":"Trying to treat the untreatable: Experimental approaches to clear rabies virus infection from the CNS","volume":"100","author":"Smith","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.idc.2012.05.001","article-title":"Rabies: Relevance, prevention, and management in travel medicine","volume":"26","author":"Hatz","year":"2012","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1017\/S0317167100054056","article-title":"Rabies in the critical care unit: Diagnostic and therapeutic approaches","volume":"38","author":"Jackson","year":"2011","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: Using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00018-007-7298-1","article-title":"Structural aspects of rabies virus replication","volume":"65","author":"Albertini","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"198790","DOI":"10.1016\/j.virusres.2022.198790","article-title":"The comparison of full G and N gene sequences from turkish rabies virus field strains","volume":"315","author":"Atici","year":"2022","journal-title":"Virus Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rojas-Sereno, Z.E., Streicker, D.G., Medina-Rodriguez, A.T., and Benavides, J.A. (2022). Drivers of Spatial Expansions of Vampire Bat Rabies in Colombia. Viruses, 14.","DOI":"10.3390\/v14112318"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-virology-100114-055157","article-title":"Everything You Always Wanted to Know about Rabies Virus (but Were Afraid to Ask)","volume":"2","author":"Davis","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-387040-7.00003-2","article-title":"Evasive strategies in rabies virus infection","volume":"79","author":"Lafon","year":"2011","journal-title":"Adv. Virus Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-387040-7.00016-0","article-title":"Design of future rabies biologics and antiviral drugs","volume":"79","author":"Smith","year":"2011","journal-title":"Adv. Virus Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.03.011","article-title":"Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus","volume":"154","author":"Anindita","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP2851","article-title":"Antiviral therapy for human rabies","volume":"20","author":"Appolinario","year":"2015","journal-title":"Antivir. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/infdis\/jiv586","article-title":"Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis","volume":"213","author":"Yamada","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.10.016","article-title":"Pyrimethamine inhibits rabies virus replication in vitro","volume":"161","author":"Rogee","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2018.01.082","article-title":"Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication","volume":"37","author":"Marosi","year":"2019","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Smith, T.G., Jackson, F.R., Morgan, C.N., Carson, W.C., Martin, B.E., Gallardo-Romero, N., Ellison, J.A., Greenberg, L., Hodge, T., and Squiquera, L. (2020). Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro. Viruses, 12.","DOI":"10.3390\/v12020177"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105016","DOI":"10.1016\/j.antiviral.2021.105016","article-title":"Broad spectrum compounds targeting early stages of rabies virus (RABV) infection","volume":"188","author":"Kali","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00204-010-0579-8","article-title":"Deoxynivalenol: Mechanisms of action, human exposure, and toxicological relevance","volume":"84","author":"Pestka","year":"2010","journal-title":"Arch. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10937400590889458","article-title":"Deoxynivalenol: Toxicology and potential effects on humans","volume":"8","author":"Pestka","year":"2005","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00204-017-2118-3","article-title":"Trichothecenes: Immunomodulatory effects, mechanisms, and anti-cancer potential","volume":"91","author":"Wu","year":"2017","journal-title":"Arch. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.fct.2013.12.043","article-title":"In vitro effect of deoxynivalenol (DON) mycotoxin on porcine reproductive and respiratory syndrome virus replication","volume":"65","author":"Savard","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.toxlet.2012.12.003","article-title":"Trichothecene toxicity in eukaryotes: Cellular and molecular mechanisms in plants and animals","volume":"217","author":"Arunachalam","year":"2013","journal-title":"Toxicol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111676","DOI":"10.1016\/j.fct.2020.111676","article-title":"The neurotoxicity of trichothecenes T-2 toxin and deoxynivalenol (DON): Current status and future perspectives","volume":"145","author":"Zhang","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bj.2021.01.005","article-title":"Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation","volume":"44","author":"Tang","year":"2021","journal-title":"Biomed. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00204-014-1280-0","article-title":"Oxidative stress-mediated cytotoxicity and metabolism of T-2 toxin and deoxynivalenol in animals and humans: An update","volume":"88","author":"Wu","year":"2014","journal-title":"Arch. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/02652030802056626","article-title":"Mechanisms of deoxynivalenol-induced gene expression and apoptosis","volume":"25","author":"Pestka","year":"2008","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk Assess."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1348-0421.1995.tb02254.x","article-title":"Antiviral activity of trichothecene mycotoxins (deoxynivalenol, fusarenon-X, and nivalenol) against herpes simplex virus types 1 and 2","volume":"39","author":"Tani","year":"1995","journal-title":"Microbiol. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.envint.2020.105949","article-title":"Low-level contamination of deoxynivalenol: A threat from environmental toxins to porcine epidemic diarrhea virus infection","volume":"143","author":"Liu","year":"2020","journal-title":"Environ. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/tbed.13600","article-title":"The impact of anthropogenic and environmental factors on human rabies cases in China","volume":"67","author":"Yu","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ftaa075","DOI":"10.1093\/femspd\/ftaa075","article-title":"Rabies virus matrix protein targets host actin cytoskeleton: A protein-protein interaction analysis","volume":"79","author":"Zandi","year":"2021","journal-title":"Pathog. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"374286","DOI":"10.4061\/2011\/374286","article-title":"Role of apoptosis in rabies viral encephalitis: A comparative study in mice, canine, and human brain with a review of literature","volume":"2011","author":"Suja","year":"2011","journal-title":"Pathol. Res. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.20506\/rst.23.2.1514","article-title":"Rabies and rabies-related viruses: A modern perspective on an ancient disease","volume":"23","author":"Cliquet","year":"2004","journal-title":"Rev. Sci. Tech."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2613.2001.iep195.x","article-title":"Viruses and apoptosis","volume":"82","author":"Thomson","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.09.006","article-title":"Deoxynivalenol induces toxicity and apoptosis in piglet hippocampal nerve cells via the MAPK signaling pathway","volume":"155","author":"Wang","year":"2018","journal-title":"Toxicon"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Behrens, M., Huwel, S., Galla, H.J., and Humpf, H.U. (2015). Blood-Brain Barrier Effects of the Fusarium Mycotoxins Deoxynivalenol, 3 Acetyldeoxynivalenol, and Moniliformin and Their Transfer to the Brain. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143640"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/phpp.12647","article-title":"Up-regulation of hsa-miR-221-3p induced by UVB affects proliferation and apoptosis of keratinocytes via Bcl-xL\/Bax pathway","volume":"37","author":"Tu","year":"2021","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10571-022-01250-3","article-title":"Role of Pyroptosis, a Pro-Inflammatory Programmed Cell Death, in Epilepsy","volume":"43","author":"Atabaki","year":"2023","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/toxins4111120","article-title":"Advances in deoxynivalenol toxicity mechanisms: The brain as a target","volume":"4","author":"Bonnet","year":"2012","journal-title":"Toxins"},{"key":"ref_39","first-page":"438","article-title":"Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line","volume":"53","author":"Lawson","year":"1989","journal-title":"Can. J. Vet. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00539-19","DOI":"10.1128\/JVI.00539-19","article-title":"Pentagalloylglucose Inhibits the Replication of Rabies Virus via Mediation of the miR-455\/SOCS3\/STAT3\/IL-6 Pathway","volume":"93","author":"Tu","year":"2019","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/01652176.2017.1343516","article-title":"Rabies-epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: A comprehensive review","volume":"37","author":"Singh","year":"2017","journal-title":"Vet. Q."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12250-012-3247-8","article-title":"Comparison of RFFIT tests with different standard sera and testing procedures","volume":"27","author":"Yu","year":"2012","journal-title":"Virol. Sin."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:22:47Z","timestamp":1760124167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24097793"],"URL":"https:\/\/doi.org\/10.3390\/ijms24097793","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}